Vizobact 1.125g Injection
Marketer
Efedra Pharmaceuticals Pvt. Ltd.
Salt Composition
Piperacillin (1000mg) + Tazobactum (125mg)
Overview Vizobact 1.125g Injection
Vizobact 1.125g Injection combines two antibiotics to combat diverse bacterial infections by eliminating microorganisms. Administration is exclusively by a healthcare provider; self-injection is strictly prohibited. Dosage and frequency are determined by your physician based on your condition's severity, adhering to the prescribed regimen. Common side effects include nausea, vomiting, diarrhea, and skin rashes, alongside potential injection site reactions such as pain, swelling, or redness. Persistent or worsening side effects necessitate immediate medical consultation. Prior to use, inform your doctor of any antibiotic allergies, kidney, or liver issues; dosage adjustments or alternative medications may be necessary. Under medical guidance, Vizobact 1.125g Injection is generally considered safe during pregnancy and breastfeeding.
Uses of Vizobact 1.125g Injection
Infections caused by bacteria
Major Benefits of Vizobact 1.125g Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Vizobact 1.125g Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Vizobact 1.125g Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Vizobact 1.125g Injection works:
Vizobact Injection (1.125g) combines piperacillin, an antibiotic that disrupts bacterial cell wall synthesis, with tazobactam, a beta-lactamase inhibitor. This combination boosts piperacillin's effectiveness by overcoming bacterial resistance mechanisms, ultimately hindering bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Vizobact 1.125g Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Vizobact 1.125g Injection is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Vizobact 1.125g Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no known harm to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Vizobact 1.125g Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Vizobact 1.125g Injection to individuals with impaired renal function. Dosage modification of Vizobact 1.125g Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Vizobact 1.125g Injection in patients with liver impairment appears to pose minimal risk. Current evidence indicates that dose modification might not be necessary for this patient group. However, physician consultation is recommended.
What if you forget to take Vizobact 1.125g Injection :
Should you forget a dose of Vizobact 1.125g Injection, seek medical advice.
Facts to Know About Vizobact 1.125g Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |



